São Paulo, October 2022 – Eurofarma announced today an agreement with IFC, a member of the World Bank Group, for a US$ 150 million (approximately R$ 775MI) loan, which will be responsible for financing part of the company's new plant in Montes Claros, Minas Gerais, and the Covid-19 vaccine production project in Itapevi, São Paulo, which is currently the group's primary production plant. The loan will help Eurofarma speed up construction in both regions and ensure that, when finished, these plants will provide society with more health alternatives. 

"We are thrilled to have access to and be a part of the IFC ecosystem, an institution with a great reputation in the market. This is another step in a long-term journey, and partnerships such as this one only reinforce our commitment to make health increasingly accessible to society," says Alexandre Palhares, Financial Administrative Vice-President at Eurofarma.

"In Brazil and the rest of Latin America and the Caribbean, investing in companies that manufacture quality and affordable pharmaceutical products is one of our top commitments.  By supporting a major pharmaceutical player, IFC will help enable access to vaccines and medicines in the region, and promote business sustainability," said Carlos Leiria Pinto, IFC General Manager in Brazil. 

Under the agreement, Eurofarma is expected to pay off the loan in eight years.

About Eurofarma Group

The Eurofarma Group has been operating in the healthcare industry for 50 years, producing and marketing innovative products and services to improve people’s quality of life. With diversified operations, it operates in all major segments, such as Medical Prescription, Prescription-Free, Generic, Hospital and Oncology, in addition to exporting and outsourcing medications. In Brazil alone, it offers more than 430 products, serves all medical specialties, and covers upwards of 200 therapeutic classes, accounting for 80% of the total market.

The Eurofarma Group is present in more than 20 countries, with 10 manufacturing plants in Latin America. Reported net sales totaled BRL 7 billion in 2021 and the Group employs over 8,800 people.

Eurofarma on social media

Facebook: @eurofarma | LinkedIn: @eurofarma

Instagram: @eurofarma | Youtube: @eurofarmalab

Press Information

G&A – Public Relations

Carolina Carone - +55 11 98578-1604 - carolina.carone@gaspar.com.br 

Guilherme Gaspar - +55 11 98285-6000 - guilherme@gaspar.com.br